Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Shipped to a 98% supplier batch specification
compound, 9%
Development of PT-141 The erectogenic signal from MT-II led to development of PT-141/bremelanotide (a related melanocortin agonist) Research Applications Pigmentation disorders : Investigated for use in vitiligo and erythropoietic protoporphyria. Skin protection : Studied for potential reduction of UV-related skin damage. Sexual function : Explored as a treatment for erectile dysfunction and female sexual arousal disorder
The consistency helps maintain steady energy, reduce brain fog, and improve metabolic output over time.* Administration: Dosage and frequency are determined based on individual needs and medical history.* Side Effects: May include mild soreness at the injection site, dry mouth, or slight digestive discomfort
This ensures it works well and is safe for the patient
Pohl, F
